Publications by authors named "Ryoko Wada"

Claim this Profile
D
Drug-induced cis-regulatory elements in human hepatocytes affect molecular phenotypes associated with adverse reactions.
Saki Gotoh-Saito, Ryoko Wada, Tomoe Nishimura, Hideya Kawaji

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2.
Gilbert Ho, Alysha Ali, Yoshiki Takamatsu, Ryoko Wada, Eliezer Masliah

Drug Discov Today· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.
Masaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama

J Alzheimers Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
Masaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama

Front Endocrinol (Lausanne)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
Jianshe Wei, Yoshiki Takamatsu, Ryoko Wada, Masayo Fujita, Gilbert Ho

Biomolecules· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin paradox as a therapeutic target of the cancer evolvability in aging.
Yoshiki Takamatsu, Gilbert Ho, Ryoko Wada, Satoshi Inoue, Makoto Hashimoto

Neoplasia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.
Makoto Hashimoto, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama

Prion· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connecting Alzheimer's Disease With Diabetes Mellitus Through Amyloidogenic Evolvability.
Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Masaaki Waragai

Front Aging Neurosci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.
Yoshiki Takamatsu, Gilbert Ho, Masaaki Waragai, Ryoko Wada, Shuei Sugama

J Alzheimers Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease.
Makoto Hashimoto, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama

J Parkinsons Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
Masayo Fujita, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Kazutaka Ikeda

Int J Mol Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future clinical utilities of Parkinson's disease and dementia biomarkers: can they help us conquer the disease?
Gilbert Ho, Yoshiki Takamatsu, Masaaki Waragai, Ryoko Wada, Shuei Sugama

Expert Rev Neurother· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability.
Makoto Hashimoto, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama

J Huntingtons Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from -Synuclein Evolvability?
Yoshiki Takamatsu, Masayo Fujita, Gilbert J Ho, Ryoko Wada, Shuei Sugama

Parkinsons Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personal factors involved in onset or progression of Ménière's disease and low-tone sensorineural hearing loss.
Masahiro Takahashi, Kyoko Odagiri, Ririko Sato, Ryoko Wada, Junichi Onuki

ORL J Otorhinolaryngol Relat Spec· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies.
Atsushi Miyamoto, Ryoko Wada, Aya Inoue, Shigeru Ishiguro, James K Liao

Life Sci· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of the daily lifestyle of patients with Meniere's disease and controls.
Junichi Onuki, Masahiro Takahashi, Kyoko Odagiri, Ryoko Wada, Ririko Sato

Ann Otol Rhinol Laryngol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Airway management during the laryngoscopic surgery for the benign laryngeal obstructive disease.
Kenji Okami, Takahide Hamano, Akihiro Sakai, Shinya Okada, Motoki Sekine, Ryoko Wada

Tokai J Exp Clin Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis